Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reading Rheum

David G. Borenstein, MD  |  Issue: August 2009  |  August 1, 2009

In response to these variances in definitions of recurrence, the investigators from Australia designed this study to answer the questions of the frequency of recurrence and the risk factors for developing recurrent episodes. A subject eligible for the study had an episode of pain for at least 24 hours but less than six weeks in the lumbar region and was preceded by a period of at least one month without back pain. The date of recovery was defined as the first day of a pain-free period of one month. Participants were asked about the development of pain at three months and 12 months and recall of back pain of at least 24 hours’ duration at 12 months. Baseline characteristics of the patients were obtained for multivariate analysis to identify factors predictive for recurrence.

Of an inception cohort of 1,334 patients with acute LPB, 353 recovered by the six-week follow-up. An interesting finding of the study that is not discussed is the almost 1,000 individuals with LBP who did not have a resolution of symptoms at six weeks. The exclusion of these individuals did not have an effect on the study results since the goal of the current study was the frequency of recurrence not the natural history of LBP recovery. Excluding these individuals affirmed the study group to be homogenous in having LBP that resolved in a timely fashion. The one-year incidence of recurrence based on recall at 12 months was 24%. When using pain assessments at three and 12 months, the one-year incidence of recurrence of LBP increased to 38%. An impressive component of the study results was the 100% follow-up rate over a 12-month period. A list of the factors examined for risk of recurrence is shown in Table 1, below. Of all the factors listed, an episode of back pain prior to entrance in the study was the sole factor with predictive value.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Overall this study has good and not-so-good news for individuals with LBP. This study offers some good news for individuals with an episode of LBP in that only about a quarter of individuals will have a recurrence of pain over a subsequent 12-month period. This recurrence rate is one of the lowest reported in medical literature. These findings pertain to individuals who are in their mid 40s and who have soft tissue problems of the lumbar spine. It does not pertain to individuals with herniated discs or spinal stenosis. The disheartening news is that LBP is the gift that keeps on giving. If you have had it once, you are at risk for a subsequent attack just because you had a previous attack. This is part of the story that cannot be modified to decrease risk. This study tells us that the best way of preventing recurrences is to prevent LBP episodes in the first place. In an attempt to decrease the risk of LBP episodes in individuals, I recommend core strengthening exercises to build up paraspinous and abdominal muscles. Using proper lifting techniques such as facing the object and using leg power can avoid the twisting injury that can be the cause of a sustained LBP episode

Page: 1 2 3 | Single Page
Share: 

Filed under:Education & TrainingResearch Rheum Tagged with:low back painPainReading RheumResearchTreatment

Related Articles

    Best Practices for Treating Non-Specific Low Back Pain

    December 16, 2015

    Low back pain (LBP) is one of the most common reasons for physician appointments. However, treatment results remain suboptimal, resulting in high rates of chronic pain, narcotic usage, surgery, depression and disability—all at great cost to individuals and the nation. One reason for this is the current practice of grouping all low back pain patients…

    Guidelines on Advice for Low Back Pain at Odds with Clinical Trial Results

    July 30, 2017

    NEW YORK (Reuters Health)—Advice is considered an effective treatment for acute low back pain (LBP), but neither clinical trials nor guidelines include adequate detail on what this advice should be, or how doctors should deliver it, according to a new review. And half of the advice topics included in guidelines were discordant with evidence from…

    Are We Playing It Safe?

    October 1, 2010

    Tumor necrosis factor alpha inhibition and the risk of solid malignancies

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences